Hiroyoshi Nishikawa

55PUBLICATIONS
325CO-AUTHORS
Genome structure and regulationMolecular targetsPredictive and prognostic markersAutoimmunityInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (55)

|Jul 14, 2026
SATB1 preserves CD4+ T-cell fidelity and establishes Treg function in antitumor immunity.

|Apr 27, 2026
Lenvatinib Combined with PD-1 Blockade Therapy Benefits Gastric Cancers through Immunosuppressive Macrophage Modulation.

|Apr 15, 2026
On-demand GLUT3 expression augments CAR T cell metabolic fitness and antitumor efficacy in preclinical models of glioblastoma.

|Apr 07, 2026
Ponatinib inhibits LCK and PI3K signaling and promotes CD8+ T stem cell memory cell development.

Yuki Okuhiro, Sachiko Ito, Keisuke Watanabe

|Feb 04, 2026
Concurrent Pituitary and Thyroid Immune-Related Adverse Events after Immune Checkpoint Inhibitors Associated with HLA-DR15-Related Haplotypes.

Tomoko Kobayashi, Shintaro Iwama, Eri Sugiyama

|Jan 27, 2026
Humoral IgG1 responses to tumor antigens underpin clinical outcomes in immune checkpoint blockade.

Edgar Gonzalez-Kozlova, Robert Sweeney, Igor Figueiredo

Pageof 10

Frequent Collaborators

13 joint publications

Shohei Koyama

11 joint publications

Yousuke Togashi

8 joint publications

Daisuke Sugiyama

8 joint publications

Kohei Shitara